Fosaprepitant composition and preparation method thereof

A technology of fosaprepitant dimeglumine and composition, which is applied in the direction of drug combination, non-active ingredients of polymer compounds, medical preparations of non-active ingredients, etc., and can solve life-threatening problems
CN112243376APending Publication Date: 2021-01-19SPES PHARMA INC

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
SPES PHARMA INC
Publication Date
2021-01-19

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present application and its embodiments teach stable compositions of fosaprepitant or a pharmaceutically acceptable salt thereof with such compositions lacking polysorbate 80 and containing dual functional excipients of hydrolysis inhibition and solubility enhancement. Further described are methods of preparation of such compositions. Among other advantages of contemplated compositions, fosaprepitant hydrolysis degradation is kept low and the compositions maintain physically and chemically stable for prolonged period.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] priority claim

[0002] This application claims priority to U.S. Application No. 16 / 245,992, filed January 11, 2019, which claims priority to U.S. Provisional Application No. 62 / 673,522, filed May 18, 2018 Right, the entire content of said application is incorporated herein by reference in its entirety. technical field

[0003] The field of the invention and its embodiments relates to stable compositions of fosaprepitant or a pharmaceutically acceptable salt thereof. In particular, the present application relates to compositions of fosaprepitant dimeglumine that do not contain polysorbate 80 or similar surfactants. Methods of preparing such compositions are further described herein. Background technique

[0004] Fosaprepitant dimeglumine is an injectable drug sold by Merck Sharp & Dohme Corp. active pharmaceutical ingredients. Fosaprepitant is a water-soluble phosphorylated prodrug of aprepitant that is rapidly converted to aprepitant in vivo after intravenous (I...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More